What the six lenses say about AARTIPHARM — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How AARTIPHARM’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.9pp | +3.3pp | +28.1pp | +39.4pp | +26.0pp | +1.9pp |
Nifty 500 Broad-market baseline | +0.9pp | +3.3pp | +27.0pp | +37.8pp | +20.2pp | -3.4pp |
Sector Own-sector index | — | — | +24.2pp | +31.8pp | +7.1pp | -24.1pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
AARTIPHARM daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
AARTIPHARM ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 555 | 458 | 538 | 564 | 386 | 418 | 432 | 583 |
| ↳ change QoQ | — | -17.5% | +17.4% | +4.9% | -31.6% | +8.3% | +3.3% | +35.0% |
| EBITDA (₹cr) | 99 | 98 | 134 | 146 | 93 | 74 | 102 | 113 |
| EBITDA margin | 17.8% | 21.4% | 24.9% | 25.9% | 24.1% | 17.7% | 23.6% | 19.4% |
| PAT (₹cr) | 55 | 55 | 74 | 88 | 50 | 28 | 48 | 61 |
| ↳ change QoQ | — | -1.5% | +35.5% | +18.9% | -43.2% | -44.0% | +71.4% | +27.1% |
| Net margin | 10.0% | 11.9% | 13.8% | 15.6% | 13.0% | 6.7% | 11.1% | 10.5% |
| EPS (₹) | 6.12 | 6.03 | 8.16 | 9.75 | 5.46 | 3.08 | 5.29 | 6.74 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding AARTIPHARM (4)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| UTI Healthcare Reg Gr | 0.73% | 1,371 | |
| WhiteOak Capital Phrm and Hlthcr Reg Gr | 0.85% | 825 | |
| Taurus Flexi Cap Gr | 0.80% | 369 | |
| Unifi Flexi Cap Reg Gr | 1.25% | 227 |
ETFs holding AARTIPHARM (0)
No tracked ETF holds AARTIPHARM ≥0.5%.